Table 2. Laboratory Findings of Patients Infected With 2019-nCoV on Admission to Hospital.
| Normal Range | Median (IQR) | P Valuea | |||
|---|---|---|---|---|---|
| Total (N = 138) | ICU (n = 36) | Non-ICU (n = 102) | |||
| White blood cell count, ×109/L | 3.5-9.5 | 4.5 (3.3-6.2) | 6.6 (3.6-9.8) | 4.3 (3.3-5.4) | .003 |
| Neutrophil count, ×109/L | 1.8-6.3 | 3.0 (2.0-4.9) | 4.6 (2.6-7.9) | 2.7 (1.9-3.9) | <.001 |
| Lymphocyte count, ×109/L | 1.1-3.2 | 0.8 (0.6-1.1) | 0.8 (0.5-0.9) | 0.9 (0.6-1.2) | .03 |
| Monocyte count, ×109/L | 0.1-0.6 | 0.4 (0.3-0.5) | 0.4 (0.3-0.5) | 0.4 (0.3-0.5) | .96 |
| Platelet count, ×109/L | 125-350 | 163 (123-191) | 142 (119-202) | 165 (125-188) | .78 |
| Prothrombin time, s | 9.4-12.5 | 13.0 (12.3-13.7) | 13.2 (12.3-14.5) | 12.9 (12.3-13.4) | .37 |
| Activated partial thromboplastin time, s | 25.1-36.5 | 31.4 (29.4-33.5) | 30.4 (28.0-33.5) | 31.7 (29.6-33.5) | .09 |
| D-dimer, mg/L | 0-500 | 203 (121-403) | 414 (191-1324) | 166 (101-285) | <.001 |
| Creatine kinase, U/L | <171 | 92 (56-130) | 102 (62-252) | 87 (54-121) | .08 |
| Creatine kinase–MB, U/L | <25 | 14 (10-18) | 18 (12-35) | 13 (10-14) | <.001 |
| Lactate dehydrogenase, U/L | 125-243 | 261 (182-403) | 435 (302-596) | 212 (171-291) | <.001 |
| Alanine aminotransferase, U/L | 9-50 | 24 (16-40) | 35 (19-57) | 23 (15-36) | .007 |
| Aspartate aminotransferase, U/L | 15-40 | 31 (24-51) | 52 (30-70) | 29 (21-38) | <.001 |
| Total bilirubin, mmol/L | 5-21 | 9.8 (8.4-14.1) | 11.5 (9.6-18.6) | 9.3 (8.2-12.8) | .02 |
| Blood urea nitrogen, mmol/L | 2.8-7.6 | 4.4 (3.4-5.8) | 5.9 (4.3-9.6) | 4.0 (3.1-5.1) | <.001 |
| Creatinine, μmol/L | 64-104 | 72 (60-87) | 80 (66-106) | 71 (58-84) | .04 |
| Hypersensitive troponin I, pg/mL | <26.2 | 6.4 (2.8-18.5) | 11.0 (5.6-26.4) | 5.1 (2.1-9.8) | .004 |
| Procalcitonin, ng/mL | |||||
| ≥0.05, No. (%) | <0.05 | 49 (35.5) | 27 (75.0) | 22 (21.6) | <.001 |
| Bilateral distribution of patchy shadows or ground glass opacity, No. (%) | NA | 138 (100) | 36 (100) | 102 (100) | >.99 |
Abbreviations: ICU, intensive care unit; IQR, interquartile range; MB, muscle and brain type; NA, not available; 2019-nCoV, 2019 novel coronavirus.
SI conversion factors: To convert alanine aminotransferase to µkat/L, multiply by 0.0167; aspartate aminotransferase to µkat/L, multiply by 0.0167; creatine kinase to µkat/L, multiply by 0.0167; and lactate dehydrogenase to µkat/L, multiply by 0.0167.
a
P values indicate differences between ICU and non-ICU patients. P < .05 was considered statistically significant.